Skip to content
Open access

The KAT2/HDACⅡa-PGK-ALDO axis constitutes a dual degradation inhibition cascade links energy stress to glycolytic amplification.

Aug 2026 · Proceedings of the National Academy of Sciences of the United States of America · Vol 123 34, pp. e2533429123 · 0 citations · 40 references
Medicine

TL;DR

A metazoan-conserved dual degradation inhibition cascade whereby energy stress coordinates acetylation-phosphorylation crosstalk that simultaneously enhances glycolytic output and suppresses two protein degradation systems is reported.

Abstract

Cells reprogram glycolysis pathway to cope with energy deficiency, in which the catalytic activity, stability, and noncanonical functions of glycolytic enzymes are finely regulated by posttranslational modifications (PTMs). Here, we report a metazoan-conserved dual degradation inhibition cascade whereby energy stress coordinates acetylation-phosphorylation crosstalk that simultaneously enhances glycolytic output and suppresses two protein degradation systems. Specifically, KAT2 (KAT2A)/HDACIIa (HDAC5)-mediated acetylation of PGK at K73 (PGK1; K75) antagonizes its ubiquitin-proteasomal degradation while strengthening its interaction with ALDO (ALDOA). Then, PGK exerts noncanonical kinase activity to phosphorylate ALDO at S272, thereby enhancing ALDO's substrate affinity and suppressing its chaperone-mediated autophagic-lysosomal degradation by inhibiting the interaction with HSC70 to simultaneously stabilize and activate ALDO to amplify glycolytic flux. This ancient survival axis underlies thermotolerance divergence in oysters and is hijacked in human lung adenocarcinoma to drive malignant proliferation. Our study integrates environmental adaptation and tumorigenesis through a unified metabolic signaling axis, broadening our understanding of PTM crosstalk in evolution and disease.

Read PDF

Similar papers

Aug 2026

FGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma

FGD5 is identified as a metabolic vulnerability that increases PDAC sensitivity to the glycolysis inhibitor 2-deoxy-D-glucose (2-DG) and a mechanistic framework supporting combinatorial strategies that couple glycolysis inhibition with perturbation of FGD5–PGK1-associated proteostasis is provided.

Wen-Ting Song, Jia-Nong Luo, Kun Cai et al. · 0 citations
Open access Aug 2026

Proteome stability and dynamic protein complex profiling identified EEF1A1 as a novel translation regulator of autophagy and mitophagy

This work integrates thermal proteome profiling with co-aggregation analysis to monitor protein thermal stability and complex assembly dynamics in response to two canonical inducers: Torin 1, which activates autophagy via mTOR inhibition, and CCCP, a mitochondrial uncoupler that triggers mitophagy.

Shuang Zhang, Ya Zeng, Feng-Ming Li et al. · 0 citations
2026

Synergetic inhibition of deubiquitinases and acetyltransferases to regulate tau acetylation and aggregation in SH-SY5Y cell line model of Alzheimer's disease.

The development of standardized cell culture models in the SH-SY5Y neuronal system will be crucial to evaluating the therapeutic potential of this synergetic inhibition strategy, thereby restoring ubiquitination and promoting tau degradation.

Basavaraju K. C., Harshitha D. K., Poornima Priyadarshini · 0 citations
Review Aug 2026

p62/SQSTM1: From an autophagy receptor to a condensate organizer of selective autophagy and stress signaling.

Upon exposure to stress, cells activate a variety of stress-response and quality-control mechanisms to maintain homeostasis. Dysregulation of these processes is implicated in numerous diseases, including cancer, liver disorders, and neurodegenerative diseases. p62/Sequestosome 1 (SQSTM1) is a multifunctional protein th...

Jun-ichi Sakamaki, Masaaki Komatsu · 0 citations
Open access Sep 2026

Oxygen-dependent subcellular redistribution of PHD3 links the hypoxic microenvironment to mitochondrial metabolic reprogramming in ccRCC

Clear cell renal cell carcinoma (ccRCC) is characterized by profound metabolic dysregulation, with both prolyl hydroxylase domain protein 3 (PHD3) and pyruvate carboxylase (PC) independently implicated in disease progression. Although each influences patient outcomes, a direct mechanistic interplay between these two re...

Jaelim Sim, Soyeon Lim, Chang-Jun Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.